Kiniksa Pharmaceuticals International (KNSA) News Today $35.88 -0.98 (-2.66%) As of 01:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock KNSA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Insider Sells 3,523 SharesSeptember 9 at 4:44 AM | insidertrades.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Rating Upgraded by Wall Street ZenSeptember 9 at 3:29 AM | marketbeat.comKiniksa Pharmaceuticals International, plc $KNSA Shares Sold by American Century Companies Inc.September 8 at 3:20 AM | marketbeat.comGranahan Investment Management LLC Sells 101,216 Shares of Kiniksa Pharmaceuticals International, plc $KNSASeptember 7 at 6:28 AM | marketbeat.comCubist Systematic Strategies LLC Takes Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 7 at 4:56 AM | marketbeat.comPDT Partners LLC Trims Stock Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 6, 2025 | marketbeat.comInvesco Ltd. Has $744,000 Stock Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 6, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Michael Megna Sells 11,000 SharesSeptember 5, 2025 | marketbeat.comEben Tessari Sells 15,091 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) StockSeptember 5, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Sets New 12-Month High - What's Next?September 5, 2025 | marketbeat.comIeq Capital LLC Acquires Shares of 43,625 Kiniksa Pharmaceuticals International, plc $KNSASeptember 5, 2025 | marketbeat.comADAR1 Capital Management LLC Reduces Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSASeptember 4, 2025 | marketbeat.comVestal Point Capital LP Invests $3.77 Million in Kiniksa Pharmaceuticals International, plc $KNSASeptember 4, 2025 | marketbeat.comBirchview Capital LP Takes $666,000 Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 4, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) CAO Sells $383,240.00 in StockSeptember 4, 2025 | insidertrades.comKiniksa Pharmaceuticals International, Plc (KNSA) Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3, 2025 | seekingalpha.comBraidwell LP Sells 1,489,538 Shares of Kiniksa Pharmaceuticals International, plc $KNSASeptember 3, 2025 | marketbeat.comTrexquant Investment LP Has $5.25 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSASeptember 3, 2025 | marketbeat.comWellington Management Group LLP Increases Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSASeptember 2, 2025 | marketbeat.comKodai Capital Management LP Takes $4.12 Million Position in Kiniksa Pharmaceuticals International, plc $KNSASeptember 1, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 42,353 Shares of Kiniksa Pharmaceuticals International, plc $KNSASeptember 1, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Lowered to Buy Rating by Wall Street ZenSeptember 1, 2025 | marketbeat.com86,203 Shares in Kiniksa Pharmaceuticals International, plc $KNSA Acquired by Walleye Capital LLCAugust 31, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Lowered to "Buy" Rating by Wall Street ZenAugust 31, 2025 | americanbankingnews.comRussell Investments Group Ltd. Has $1.88 Million Holdings in Kiniksa Pharmaceuticals International, plc $KNSAAugust 29, 2025 | marketbeat.comKiniksa Pharmaceuticals to Present at Upcoming Investor ConferencesAugust 28, 2025 | globenewswire.comVanguard Group Inc. Has $74.61 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSAAugust 26, 2025 | marketbeat.comFox Run Management L.L.C. Invests $252,000 in Kiniksa Pharmaceuticals International, plc $KNSAAugust 23, 2025 | marketbeat.comNuveen LLC Makes New $16.99 Million Investment in Kiniksa Pharmaceuticals International, plc $KNSAAugust 23, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Recommendation of "Buy" from BrokeragesAugust 23, 2025 | marketbeat.comEben Tessari Sells 16,200 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) StockAugust 21, 2025 | insidertrades.comAlgert Global LLC Has $5.12 Million Position in Kiniksa Pharmaceuticals International, plc $KNSAAugust 21, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Hits New 12-Month High - Here's What HappenedAugust 20, 2025 | marketbeat.comDeutsche Bank AG Buys 252,125 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)August 17, 2025 | marketbeat.comInsider Selling: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Director Sells 49,407 Shares of StockAugust 16, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Director Thomas Malley Sells 50,129 SharesAugust 16, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Director Thomas Malley Sells 78,233 SharesAugust 16, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Director Sells $1,600,786.80 in StockAugust 15, 2025 | insidertrades.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.August 13, 2025 | marketbeat.comJohn F. Paolini Sells 29,325 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) StockAugust 10, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Insider John F. Paolini Sells 29,325 SharesAugust 9, 2025 | insidertrades.comEben Tessari Sells 138,614 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) StockAugust 8, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Eben Tessari Sells 138,614 SharesAugust 8, 2025 | insidertrades.comMichael R. Megna Sells 17,000 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) StockAugust 7, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) CFO Sells $621,259.21 in StockAugust 7, 2025 | marketbeat.comKiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) CAO Sells $549,950.00 in StockAugust 7, 2025 | insidertrades.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 52-Week High - What's Next?August 5, 2025 | marketbeat.comBIT Capital GmbH Invests $264,000 in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA)August 4, 2025 | marketbeat.comKiniksa Pharmaceuticals International (NASDAQ:KNSA) Raised to Strong-Buy at Wall Street ZenAugust 3, 2025 | marketbeat.comWedbush Research Analysts Lift Earnings Estimates for KNSAAugust 2, 2025 | marketbeat.com Get Kiniksa Pharmaceuticals International News Delivered to You Automatically Sign up to receive the latest news and ratings for KNSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KNSA Media Mentions By Week KNSA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KNSA News Sentiment▼0.830.84▲Average Medical News Sentiment KNSA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KNSA Articles This Week▼216▲KNSA Articles Average Week Get the Latest News and Ratings for KNSA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals International and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BridgeBio Pharma News Moderna News Verona Pharma PLC American Depositary Share News Elanco Animal Health News Roivant Sciences News Revolution Medicines News Grifols News Rhythm Pharmaceuticals News Legend Biotech News Abivax News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KNSA) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredWall Street legend: “Put $1,000 in this AI stock”A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiniksa Pharmaceuticals International, plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiniksa Pharmaceuticals International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KNSA Stock Alerts